Cyanocobalamin Injection Recalled for Subpotent Drug - Out of Specification Assay
Aurobindo Pharma USA Inc. is recalling 433,809 vials of Cyanocobalamin injection nationwide because assay testing showed the drug is subpotent, containing less than the specified 1,000 mcg/mL of active ingredient. Affected lots with specific expiration dates from September 2022 to April 2023 are identified for recall.
- Product
- CYANOCOBALAMIN — CYANOCOBALAMIN (CYANOCOBALAMIN)
- Category
- Drug
- Distribution
- Distributed nationwide